Proton therapy combo aims to shrink pancreatic tumors before surgery

NCT ID NCT04894643

Recruiting now Disease control Sponsor: EBG MedAustron GmbH Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests a new approach for people with borderline resectable pancreatic cancer, where the tumor is close to important blood vessels but may still be removable. Participants first receive chemotherapy, then proton beam radiation combined with more chemo, followed by surgery if possible. The goal is to see if this treatment is safe and helps control the disease before and after surgery.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PANCREATIC CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

malignant pancreatic neoplasm pancreatic neoplasm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

PANCREATIC CANCER PROTON THERAPY

Contacts and locations

Locations

Department of Surgery, LK Wiener Neustadt
RECRUITING

Wiener Neustadt, 2700, Austria
EBG MedAustron GmbH
RECRUITING

Wiener Neustadt, Lower Austria, 2700, Austria

More trials for these conditions

Other studies related to the condition(s) this trial covers.